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INTRODUCTION
pressive disorder in patients with RLS compared with healthy controls. As depression is well known to compromise cognitive functioning, 13 depression might be a contributing factor to the cognitive deficit observed in patients with RLS. Furthermore, RLS-related sleep loss might cause depressive symptoms, and vice versa. Therefore, depression should be taken into consideration when evaluating cognition in RLS. However, only a few studies have examined whether depression is associated with cognitive dysfunction in RLS patients. These studies have revealed that, in RLS patients, depression does have an impact on cognitive function. 2, 3, 8, 9 The aim of the present study was to investigate cognitive function as measured with a comprehensive neuropsychological test battery in drug-naïve RLS patients, compared to age-matched healthy controls. Depression was also evaluated, and was taken into consideration in the interpretation of cognitive function in RLS patients.
METHODS

Subjects
All subjects signed written informed consents. The experimental protocol was approved by the local ethics committee. The diagnosis of RLS was made based on the diagnostic criteria established by the International RLS Study Group.
14 The inclusion criteria were: 1) age 18-70 years, 2) RLS symptom duration longer than 1 year, 3) International RLS Severity Scale (IRLS) score > 19, and 4) no prior treatment for RLS. Patients whose symptoms were associated with secondary RLS such as pregnancy, chronic kidney disease or peripheral neuropathy, or who had sleep disorders other than RLS were excluded from the study. An age-matched group of healthy volunteers participated as controls. Subjects were included as healthy controls in the present study only if they were in the normal range in a sleep questionnaire and not identified as having RLS during a faceto-face interview.
The structured sleep questionnaire included the Global Sleep Assessment Questionnaire, 15 the Pittsburgh Sleep Quality Index (PSQI), 16 the Epworth Sleepiness Scale (ESS), 17 and the Insomnia Severity Index (ISI). 18 RLS severity was determined using the IRLS.
19
Neuropsychological Assessment
The neuropsychological test battery included: 1) Digit span forward and backward to assess attention span, 20 2) Short form of the Korean-Boston Naming Test to evaluate language function using confrontational naming skills, 21 3) Rey-Osterrieth Complex Figure Test to 
Depression Assessment
Subjects completed the 21-item Korean version of the Beck Depression Inventory II (BDI-II) to assess the intensity of depression. 30 The standard cut-offs are as follows: 0-13 indicates minimal depression; 14-19 indicates mild depression; 20-28 indicates moderate depression; and 29-63 indicates severe depression. Higher scores on BDI-II are associated with more intense depression.
The Korean version of the BDI-II has good reliability and validity as a measure to assess severity of depressive symptoms in patients and nonclinical populations. 30, 31 The BDI-II has been widely applied to identify RLS patients with depression, and is a useful tool in the studies of RLS patients.
32,33
Statistical Analyses
Chi-square and Mann-Whitney U tests were used to compare RLS patients with controls. Spearman correlations were conducted to determine the correlation between clinical and sleeprelated variables and depression scores in the RLS group. p < 0.05 was considered to indicate statistical significance. ferent between the two groups. However, RLS patients had worse ISI and PSQI scores than controls, proving that RLS patients had more insomnia and poorer sleep quality (Table 2) .
RESULTS
Demographic Data and Sleep-Related Variables
Neuropsychological Tests
Within the cognitive domain of memory, significant group differences were observed on the K-CVLT word recognition test. Within the executive function domain, significant group differences were seen on the COWAT test of category word fluency: animal. On both tests, RLS patients performed slightly but significantly better than controls (p < 0.05) ( Table 3 ).
Depression and Correlation with Cognition
The RLS group had a significantly higher BDI-II score compared with the control group (6 vs. 16, p = 0.005) ( Table 3) . RLS patients had a BDI-II score that was significantly correlated with IRLS (r = 0.619, p = 0.014), ISI (r = 0.757, p = 0.001), and PSQI (r = 0.583, p = 0.022).
Nine (52.9%) out of 17 RLS patients had depression, and six patients had no depression. Six patients (35.3%) showed moderate to severe depression. We compared cognitive function between patients with moderate to severe depression (n = 6) and those without depression (n = 6). There was no significant difference in cognitive function between the two groups.
DISCUSSION
The present study was performed to investigate the differences in cognitive function and depression between drug-naïve RLS patients and healthy controls. The main findings of this study were 1) RLS patients do not exhibit cognitive decline compared to age-matched control subjects, 2) RLS patients experienced more depression than control subjects, and 3) the depression in patients with RLS had little impact on cognitive function, but were independently associated with symptoms of RLS regardless of cognitive function.
Inconsistent findings using neuropsychological tests have been reported in patients with RLS. Some studies have reported cognitive dysfunction in the domain of frontal lobe functions. However, other studies revealed no differences in cognition between RLS patients and control subjects. Our study demonstrated higher performance in verbal memory and word fluency in patients with RLS compared to control subjects. There are some explanations for the normal cognitive function in our patients. Self-reported sleep duration was not different between patients and control subjects, although our patients had severe RLS symptomatology as well as significant sleep disturbances. Adaptation to the effects of chronic sleep disturbances in RLS may reduce the contribution of sleep loss to cognitive function in these patients. An alerting mechanism that is associated with an enhanced level of physiologic alertness in RLS 8 may operate to mitigate some effects of sleep disruption on cognitive function.
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A recent neuroimaging study showed significant regional decreases of gray matter volume in multiple cortical regions including the left hippocampal gyrus, both parietal lobes, medial frontal areas, and cerebellum in patients with RLS. 34 These findings suggest cortical dysfunction in RLS patients. Moreover, ERP studies demonstrated clearly decreased P300 amplitudes in oddball and Sternberg working memory tasks. Therefore, subtle cognitive decline in RLS could be revealed by sophisticated neuroimaging or neurophysiological methods.
We found that the RLS patients scored higher on the depression evaluation than the control group. About half of the patients suffered from depression, and one third of the patients showed moderate to severe depression. This figure is comparable to previous studies. [12] [13] [14] The depression score showed a significant positive correlation with both sleep disturbance and RLS severity. To identify whether depression had impact on cognitive function, we compared cognitive function between patients with moderate to severe depression and those without depression. We found no significant difference in cognitive function regardless of whether the patients had depression. This result indicates that depression might not be an important factor affecting cognition in patients with RLS. However, our small sample size may have introduced statistical bias and precludes us from drawing a firm conclusion from our results. Further studies with larger sample sizes will be required to corroborate our results.
Nevertheless, some points regarding our study are worth mentioning. The present study targeted drug-naïve patients with RLS. Most previous studies have weaned participants off RLSrelated medications before examining the impact of untreated RLS symptoms on cognitive function. Our study recruited only drug-naïve RLS patients so that we could independently examine the effect of RLS symptoms on cognitive performance, excluding any secondary effects caused by the sudden termination of RLS treatment. In addition, cognitive performance was compared with healthy control subjects without RLS in multiple domains, using a comprehensive battery of neuropsychological tests along with an evaluation of depression.
In conclusion, patients with RLS may not show cognitive dysfunction when evaluated by comprehensive neuropsychological tests. In addition, depression is likely to have little impact on cognitive function, but may be associated with RLS symptoms.
